Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Warren E. Rose"'
Autor:
Chao Li, Sue McCrone, Jay W. Warrick, David R. Andes, Zachary Hite, Cecilia F. Volk, Warren E. Rose, David J. Beebe
Publikováno v:
Lab on a Chip. 23:2005-2015
Under-oil open microfluidic systems (UOMS)-antimicrobial susceptibility testing (AST) integrated with a cloud lab technique provides a versatile platform for rapid phenotypic AST with a sample-to-report turnaround time in around 4 h.
Autor:
Laurel Legenza, Renier Coetzee, Warren E. Rose, Tasneem Esack, Kenneth Crombie, Megan Mina, Nasia Safdar, Susanne G. Barnett
Publikováno v:
Research in Social and Administrative Pharmacy. 18:4100-4111
Clostridioides difficile infection (CDI) contributes the global threats of drug resistant infections, healthcare acquired infections and antimicrobial resistance. Yet CDI knowledge among healthcare providers in low-resource settings is limited and CD
Autor:
Fan Zhang, René F. Ramos Alvarenga, Kurt Throckmorton, Shaurya Chanana, Doug R. Braun, Jen Fossen, Miao Zhao, Sue McCrone, Mary Kay Harper, Scott R. Rajski, Warren E. Rose, David R. Andes, Michael G. Thomas, Tim S. Bugni
Publikováno v:
Organic Letters. 24:3998-4002
Autor:
Erin K McCreary, Matthew A. Baker, Warren E. Rose, Michael J. Trisler, Kenneth Copeland, Dan Smelter, Thomas J Dilworth
Publikováno v:
The Journal of Clinical Pharmacology. 62:472-478
Oritavancin and dalbavancin are long-acting lipoglycopeptides with activity against susceptible gram-positive bacteria, including methicillin-resistant Staphylococcus aureus. Though similar in structure to traditional glycopeptide antibiotics like va
Autor:
Ryan D. Ward, Jennifer S. Tran, Amy B. Banta, Emily E. Bacon, Warren E. Rose, Jason M. Peters
The emergence of multidrug-resistant Gram-negative bacteria underscores the need to define genetic vulnerabilities in relevant pathogens. The Gram-negative pathogen,Acinetobacter baumannii, poses an urgent threat by evading antibiotic treatment throu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ebc22870c70711d04863f6e8d25fbe1
https://doi.org/10.1101/2022.11.09.515830
https://doi.org/10.1101/2022.11.09.515830
Autor:
Lucas T Schulz, Dan Fleischman, Stuart Burke, David R. Andes, Megan E Klatt, Warren E. Rose, Alexander J. Lepak, Dave Grinder, Barry C. Fox
Publikováno v:
American Journal of Health-System Pharmacy. 78:2256-2264
Purpose Small community hospitals often lack the human, financial, and technological resources necessary to implement and maintain successful antimicrobial stewardship programs now required by national regulatory and accrediting bodies. Creative solu
Publikováno v:
Critical care explorations. 4(7)
β-lactams are the cornerstone of empiric and targeted antibiotic therapy for critically ill patients. Recently, there have been calls to use β-lactam therapeutic drug monitoring (TDM) within 24-48 hours after the initiation of therapy in critically
Autor:
Chao Li, Sue McCrone, Jay W. Warrick, David R. Andes, Zachary Hite, Cecilia F. Volk, Warren E. Rose, David J. Beebe
Antimicrobial susceptibility testing (AST) remains the cornerstone of effective antimicrobial selection and optimization in patients. Despite recent advances in rapid pathogen identification and resistance marker detection with molecular diagnostics,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58c622b648339accc0a89b3815c66fba
https://doi.org/10.1101/2022.06.24.22276877
https://doi.org/10.1101/2022.06.24.22276877
Publikováno v:
The Journal of infectious diseases.
Background Clostridioides difficile infections (CDI) and recurrence (rCDI) are major health care burdens. Recurrence is likely caused by spores in the gastrointestinal tract that germinate after antibiotic therapy. This murine study explores germinan
Autor:
Cassandra Lew, Molly Pellitteri Hahn, Cameron Scarlett, Aaron Rottier, Andrew D. Berti, Richard A. Proctor, Arnold S. Bayer, Warren E. Rose
Publikováno v:
Antimicrob Agents Chemother
Clinical treatment options for daptomycin (DAP)-resistant (DAP-R), methicillin-resistant Staphylococcus aureus (MRSA) infections are relatively limited. Current therapeutic strategies often take advantage of potential synergistic activity of DAP plus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c16429f8e704472f16f62892674e1b56
https://europepmc.org/articles/PMC8923230/
https://europepmc.org/articles/PMC8923230/